These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inhibition of platelet aggregation by 5-nitro-2-furaldehyde diacetate with observations on structure-activity relationships. Rossi EC; Nimer S; Louis G J Lab Clin Med; 1976 Apr; 87(4):703-9. PubMed ID: 1270881 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of adrenaline and adenosine diphosphate induced platelet aggregation by Lansberg's hognose pit viper (Porthidium lansbergii hutmanni) venom. Lopez-Johnston JC; de Bosch N; Scannone H; Rodríguez-Acosta A Ann Hematol; 2007 Dec; 86(12):879-85. PubMed ID: 17891398 [TBL] [Abstract][Full Text] [Related]
6. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Fontana P; Dupont A; Gandrille S; Bachelot-Loza C; Reny JL; Aiach M; Gaussem P Circulation; 2003 Aug; 108(8):989-95. PubMed ID: 12912815 [TBL] [Abstract][Full Text] [Related]
7. Proceedings: Time-dependent potentiation and inhibition by 5-hydroxytryptamine of platelet aggregation induced by ADP. Michal F; Motamed M Br J Pharmacol; 1975 Jun; 54(2):221P-222P. PubMed ID: 1148513 [No Abstract] [Full Text] [Related]
8. Leukocyte count and leukocyte ecto-nucleotidase are major determinants of the effects of adenosine triphosphate and adenosine diphosphate on platelet aggregation in human blood. Glenn JR; White AE; Johnson A; Fox SC; Behan MW; Dolan G; Heptinstall S Platelets; 2005; 16(3-4):159-70. PubMed ID: 16011960 [TBL] [Abstract][Full Text] [Related]
9. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor. Pampuch A; Cerletti C; de Gaetano G Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and inhibition of platelet aggregation for some 1-o-chlorophenyl-1,2,3,4-tetrahydroisoquinoline derivatives. Yang J; Hua WY; Wang FX; Wang ZY; Wang X Bioorg Med Chem; 2004 Dec; 12(24):6547-57. PubMed ID: 15556771 [TBL] [Abstract][Full Text] [Related]
11. Binding of fibrinogen to ADP-treated platelets. Comparison of plasma fibrinogen fractions and early plasmic fibrinogen derivatives. Peerschke EI; Galanakis DK J Lab Clin Med; 1983 Mar; 101(3):453-60. PubMed ID: 6827176 [TBL] [Abstract][Full Text] [Related]
12. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis. Glenn JR; White AE; Johnson AJ; Fox SC; Myers B; Heptinstall S Platelets; 2008 Feb; 19(1):59-69. PubMed ID: 18231939 [TBL] [Abstract][Full Text] [Related]
13. Heparin counteracts the antiaggregating effect of prostacyclin by potentiating platelet aggregation. Bertelé V; Roncaglioni MC; Donati MB; de Gaetano G Thromb Haemost; 1983 Apr; 49(2):81-3. PubMed ID: 6346573 [TBL] [Abstract][Full Text] [Related]
14. The ability of poloxamers to inhibit platelet aggregation depends on their physicochemical properties. Ahmed F; Alexandridis P; Shankaran H; Neelamegham S Thromb Haemost; 2001 Dec; 86(6):1532-9. PubMed ID: 11776324 [TBL] [Abstract][Full Text] [Related]
15. Deaggregation is an integral component of the response of platelets to ADP in vitro: kinetic studies of literature and original data. Maayani S; Tagliente TM; Schwarz T; Craddock-Royal B; Alcala C; Marrero G; Martinez R Platelets; 2001 Aug; 12(5):279-91. PubMed ID: 11487380 [TBL] [Abstract][Full Text] [Related]
16. Role of intracellular signaling events in ADP-induced platelet aggregation. Daniel JL; Dangelmaier C; Jin J; Kim YB; Kunapuli SP Thromb Haemost; 1999 Oct; 82(4):1322-6. PubMed ID: 10544922 [TBL] [Abstract][Full Text] [Related]
17. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation. Cook JJ; Sitko GR; Holahan MA; Stranieri MT; Glass JD; Askew BC; McIntyre CJ; Claremon DA; Baldwin JJ; Hartman GD; Gould RJ; Lynch JJ J Pharmacol Exp Ther; 1997 May; 281(2):677-89. PubMed ID: 9152373 [TBL] [Abstract][Full Text] [Related]
18. Effect of prostaglandins and drotaverine on ADP-induced platelet aggregation. Losonczy H; Nagy I; Gregus Z Acta Med Acad Sci Hung; 1974; 31(3-4):157-63. PubMed ID: 4469713 [No Abstract] [Full Text] [Related]
19. Two different inhibitory effects of pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid on adenosine diphosphate-induced human platelet aggregation. Windscheif U; Radziwon P; Breddin HK; Bäumert HG; Lambrecht G; Mutschler E Arzneimittelforschung; 1995 Sep; 45(9):994-7. PubMed ID: 7488321 [TBL] [Abstract][Full Text] [Related]